62 studies found for:    Open Studies | "Adenoviridae Infections"
Show Display Options
Rank Status Study
21 Recruiting Study of Recombinant Adenovirus AdVince in Patients With Neuroendocrine Tumors; Safety and Efficacy
Condition: Neuroendocrine Tumors
Intervention: Drug: AdVince
22 Unknown  A Pilot Study of Filtrum-STI in Children With Viral Gastroenteritis
Condition: Viral Gastroenteritis
Interventions: Drug: Filtrum-STI (lignin hydrolytic);   Drug: Placebo
23 Unknown  Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Biological: Recombinant DNA- pVAX/L523S;   Biological: Recombinant adenovirus- Ad/L523S
24 Recruiting MG1 Maraba/MAGE-A3, With and Without Adenovirus Vaccine, With Transgenic MAGE-A3 Insertion in Patients With Incurable MAGE-A3-Expressing Solid Tumours
Condition: Advanced/Metastatic Solid Tumours
Interventions: Biological: MG1MA3;   Biological: AdMA3
25 Not yet recruiting Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients
Conditions: Malignant Hydrothorax;   Non Small Cell Lung Cancer
Interventions: Drug: Gemcitabine;   Drug: Vinorelbine;   Drug: Paclitaxel;   Drug: Pemetrexed;   Drug: Oncorine;   Drug: Endostar;   Drug: Cisplatin
26 Recruiting A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming GM-CSF Coding Oncolytic Adenovirus, and Pemetrexed/Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma
Condition: To Determine Safety, Tolerability and Efficacy of ONCOS-102 in Combination With Chemotherapy
Interventions: Biological: ONCOS-102;   Drug: Pemetrexed/cisplatin;   Drug: Cyclophosphamide
27 Not yet recruiting LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: LOAd703;   Drug: Gemcitabine;   Drug: nab-paclitaxel
28 Recruiting Anti-virus Treatment Following Bone Marrow Transplant
Conditions: Allogeneic Stem Cell Transplant;   Viral Infection;   Viral Reactivation
Intervention: Biological: Viral specific CTL Infusion
29 Recruiting Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer
Condition: Prostate Cancer
Intervention: Biological: Ad5-yCD/mutTKSR39rep-hIL12
30 Recruiting Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant
Condition: Infection
Intervention: Biological: Multivirus Specific T cells
31 Recruiting DNX-2401 With Interferon Gamma (IFN-γ) for Recurrent Glioblastoma or Gliosarcoma Brain Tumors
Condition: Glioblastoma or Gliosarcoma
Interventions: Drug: Single intratumoral injection of DNX-2401;   Drug: Interferon-gamma
32 Unknown  ADenoVirus Initiative Study in Epidemiology in Spain
Condition: Viral Conjunctivitis
Intervention:
33 Unknown  ADenoVirus Initiative Study in Epidemiology in Germany
Condition: Viral Conjunctivitis
Intervention:
34 Recruiting Study of a Recombinant Adenovirus to Treat Localized Prostate Cancer
Condition: Localized Prostate Cancer
Intervention: Drug: Ad5-SGE-REIC/Dkk3
35 Recruiting Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals
Condition: Cocaine Dependence
Interventions: Biological: dAd5GNE Vaccine;   Biological: Placebo
36 Not yet recruiting Ad-HGF Treatment for Myocardial Infarction
Condition: Myocardial Infarction
Interventions: Drug: Ad-HGF;   Other: 0.9% NaCl
37 Recruiting Multivirus-specific Cytotoxic T Lymphocytes (mCTL)
Condition: Refractory Viral Infections
Intervention: Biological: mCTLs
38 Unknown  Trial of E10A in Head and Neck Cancer
Conditions: Head and Neck Squamous Carcinoma;   Nasopharyngeal Carcinoma
Interventions: Drug: E10A;   Drug: Cisplatin;   Drug: Paclitaxel
39 Recruiting Allogeneic Virus-specific T Cell Lines (VSTs)
Condition: Viral Infections After HSCT
Intervention: Biological: VSTs
40 Recruiting Registry on Salvage Antiviral Treatment for Patients Experiencing ADV and / or CMV Reactivation Post Allogeneic HSCT
Condition: Infectious Complications Following HSCT
Intervention: Other: antiviral therapies for CMV and/or ADV

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years